Fatty fish in the diet of patients with type 2 diabetes: Comparison of the metabolic effects of foods rich in n-3 and n-6 fatty acids

American Journal of Clinical Nutrition

Volumn 94, Issue 1, 2011, Pages 26-33

  Karlström, Brita E ^b   Järvi, Anette E ^a   Byberg, Liisa ^b   Berglund, Lars G ^b   Vessby, Bengt O H ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LINOLEIC ACID; LIPOPROTEIN; MALONALDEHYDE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET THERAPY; FEMALE; FISH; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE URINE LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN METABOLISM; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADULT; AGED; ANIMALS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL ESTERS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FISHES; HUMANS; LIPOPROTEINS; MALE; MALONDIALDEHYDE; MIDDLE AGED; TOCOPHEROLS;

EID: 79959453395     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.006221     Document Type: Article

References (43)

1. Mann JI, De Leeuw I, Hermansen K, et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis 2004;14:373-94. (Pubitemid 40459260)
2. American Diabetes Association. Nutrition recommendations and interventions for diabetes. A position statement of the American Diabetes Association. Diabetes Care 2008;31:S61-78.
3. Garg A, Bonanome A, Grundy SM, Zhang Z-J, Unger RH. Comparison of a high-carbohydrate diet with a high-monounsaturated fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988;319:829-34.
4. Garg A, Grundy SM, Unger RH. Comparison of effects of high and low carbohydrate diets on plasma lipoprotein and insulin sensitivity in patients with mild NIDDM. Diabetes 1992;41:1278-85.
5. Campbell LV, Borkman M, Marmot PE, Storlien LH, Dyer JA. The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care 1994;17:177-82. (Pubitemid 24065513)
6. Heine RJ, Mulder C, Popp-Snijders C, van der Meer J, van der Veen Ed A. Linoleic-acid-enriched diet: long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in non-insulin-dependent diabetic patients. Am J Clin Nutr 1989;49:448-56. (Pubitemid 19107256)
7. Houtsmuller AJ, van Hal-Ferwerda J, Zahn KJ, Henkes KE. Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutr Metab 1980;24(suppl 1):105-18. (Pubitemid 11252124)
8. Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tomkin GH. Oxidation of low-density lipoprotein in NIDDM: its relationship to fatty acid composition. Diabetologia 1995;38:1300-6.
9. Malasanos TH, Stacpoole PW. Biological effects of w-3 fatty acids in diabetes mellitus. Diabetes Care 1991;14:1160-79.
10. Vessby B. Dietary supplementation with n-3 polyunsaturated fatty acids in type 2 diabetes - effects on glucose homeostasis. Ann N Y Acad Sci 1993;683:244-9. (Pubitemid 23236674)
11. Friedberg CE, Janssen MJFM, Heine RJ, Grobbee DE. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998;21:494-500. (Pubitemid 28172922)
12. Montori VM, Farmer A, Wollan PC, Dinneen SF. Fish oil supplementation in type 2 diabetes. A quantitative systematic review. Diabetes Care 2000;23:1407-15.
13. MacLean CH, Mojica WA, Morton SC et al. Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. Evid Rep Technol Assess (Summ) 2004;89:1-4.
14. Kaushik M, Mozaffarian D, Spiegelman D, Manson JE, Willett WC, Hu FB. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am J Clin Nutr 2009;90:613-20.
15. Boberg M, Pollare T, Siegbahn A, Vessby B. Supplementation with n-3 fatty acids reduces triglycerides but increases PAI-1 in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1992;22:645-50.
16. Hansen J, Grimsgaard S, Nordoy A, Bonaa KH. Dietary supplementation with highly purified eicosapentaenoic acid and docosahexaenoic acid does not influence PAI-1 activity. Thromb Res 2000;98:123-32. (Pubitemid 30122300)
17. Sanders TA, Lewis F, Slaughter S, et al. Effect of varying the ratio of n-6 to n-3 fatty acids by increasing the dietary intake of alpha-linolenic acid, eicosapentaenoic and docosahexaenoic acid, or both, on fibrinogen and clotting factors VII and XII in persons aged 45-70 Y: the OPTILIP study. Am J Clin Nutr 2006;84:513-22. (Pubitemid 44713400)
18. National Food Administration. PC-Kost database. Uppsala, Sweden: National Food Administration, 1996.
19. Havel RJ, Eder HA, Bragdon JH. The determination and chemical composition ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
20. Seigler L, Wu WT. Separation of serum high-density lipoprotein for cholesterol determination: ultracentrifugation vs precipitation with sodium phosphotungstate and magnesium chloride. Clin Chem 1981;27:834-41.
21. Boberg M, Croon LB, Gustafsson IB, Vessby B. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin Sci 1985;68:581-7. (Pubitemid 15103439)
22. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
23. Eriksson E, Rånby M, Gyzander E, Risberg B. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay. Thromb Res 1988;50:91-101.
24. Öhrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal obesity. J Intern Med 1993;234:53-60. (Pubitemid 23240558)
25. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different lipids to express serum tocopherol:lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 1986;23:514-20. (Pubitemid 16042484)
26. Öhrvall M, Tengblad S, Ekstrand B, Siegbahn A, Vessby B. Malondialdehyde concentration in plasma is inversely correlated to the proportion of linoleic acid in serum lipoprotein lipids. Atherosclerosis 1994;108:103-10. (Pubitemid 24216373)
27. Jones B, Kenward MG. Design and analysis of cross-over trials. 2nd ed. London, United Kingdom: Chapman and Hall, 2003.
28. Nestel PJ, Connor WE, Reardon MF, Connor S, Wong S, Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 1984;74:82-9. (Pubitemid 14086047)
29. Fisher WR, Zech LA, Stacpoole PW. Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet. J Lipid Res 1998;39:388-401. (Pubitemid 28100676)
30. Frénais R, Ouguerram K, Maugeais C, et al. Effect of dietary omega-3 fatty acids on high-density lipoprotein AI kinetics in type II diabetes mellitus. Atherosclerosis 2001;1567:131-5. (Pubitemid 32539362)
31. Vessby B. Diet and lipoprotein(a). Nutr Metab Cardiovasc Dis 1996;6:239-44. (Pubitemid 126491617)
32. Vessby B, Karlström B, Boberg M, Lithell H, Berne C. Polyunsaturated fatty acids may impair blood glucose control in type 2 diabetic patients. Diabet Med 1992;9:126-33.
33. Vessby B. Dietary fat and insulin action in humans. Br J Nutr 2000;83(suppl 1):S91-6.
34. Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V. Effects of n-3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 2006;84:540-50. (Pubitemid 44713403)
35. Griffin MD, Sanders TA, Davies IG, et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 2006;84:1290-8. (Pubitemid 44912809)
36. Marckmann P. Dietary treatment of thrombogenic disorders related to the metabolic syndrome. Br J Nutr 2000;83(suppl 1):S121-6.
37. Nilsson L, Banti C, Diczfalusy U, Tremoli E, Hamsten A, Eriksson P. Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:1679-85. (Pubitemid 28521055)
38. Byberg L, Smedman A, Vessby B, Lithell H. Plasminogen activator inhibitor-1 and relations to fatty acid composition in the diet and in serum cholesterol esters. Arterioscler Thromb Vasc Biol 2001;21:2086-92. (Pubitemid 34219766)
39. Ntambi JM, Miyazaki M. Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res 2004;43:91-104. (Pubitemid 37487985)
40. Warensjö E, Riserus U, Vessby B. Fatty acid composition of serum lipids predicts the development of the metabolic syndrome in men. Diabetologia 2005;48:1999-2005. (Pubitemid 41416909)
41. Warensjö E, Sundström J, Vessby B, Cederholm T, Risérus U. Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population based study. Am J Clin Nutr 2008;88:203-9. (Pubitemid 351988700)
42. Kesavulu MM, Kameswararao B, Apparao C, Kumar EG, Harinarayan CV. Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes Metab 2002;28:20-6. (Pubitemid 34168746)
43. Parfitt VJ, Desomeaux K, Bolton CH, Hartog M. Effects of high monounsaturated and polyunsaturated fat diets on plasma lipoproteins and lipid peroxidation in type 2 diabetes mellitus. Diabet Med 1994;11:85-91. (Pubitemid 24040548)